Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ortega, O.
Right arrow Articles by Vigil, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ortega, O.
Right arrow Articles by Vigil, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 1105-1109
© 2002 European Renal Association-European Dialysis and Transplant Association


Preliminary Report

Significance of high C-reactive protein levels in pre-dialysis patients

Olimpia Ortega1,, Isabel Rodriguez1, Paloma Gallar1, Agustín Carreño1, Milagros Ortiz1, Beatriz Espejo1, Juana Jimenez2, Magdalena Gutierrez1, Aniana Oliet1 and Ana Vigil1

1 Department of Nephrology and 2 Laboratory, Hospital Severo Ochoa, Leganés, Madrid, Spain

Background. An elevated serum C-reactive protein (CRP) has been shown to be strongly predictive of morbidity and mortality in dialysis patients. However, the significance of high CRP levels in the pre-dialysis period has not been studied extensively. The aim of our study was to analyse the evolution of our pre-dialysis population according to their basal levels of CRP.

Methods. A cohort of 66 pre-dialysis patients was followed for 1 year, after initial determination of serum CRP. The evolution of blood pressure (BP) control, CRP levels, nutritional data (body mass index, serum albumin, prealbumin, transferrin, cholesterol), proteinuria, calcium-phosphorus product, bicarbonate, haemoglobin (Hb), the weekly dose of erythropoietin (Epo)/kg body weight, and the Hb/Epo dose ratio were measured and compared between patients with high (>6 mg/l) or low (<6 mg/l) CRP levels at baseline. The decline in renal function, hospitalization, and death also were measured and compared between the two groups.

Results. At baseline, 23 patients (35%) showed high (>6 mg/l) CRP levels. CRP was higher in patients with a previous history of cardiovascular disease (P<0.01), as well as in patients in whom ischaemic nephropathy or nephrosclerosis was the cause of end-stage renal disease (P<0.01). There were no differences between diabetic and non-diabetic patients. During the study period, patients with higher CRP levels at baseline maintained higher levels (P<0.001). During this period, these patients showed lower (P<0.05) albumin concentration, higher bicarbonate levels, lower Hb concentration, and lower Hb/Epo ratio and needed higher Epo doses. There were no differences in systolic BP, the degree of proteinuria, and the decline in renal function between groups; diastolic BP was lower in patients with high CRP levels. Hospitalization was higher (P<0.005) in this group. Only one patient died.

Conclusions. The prevalence of inflammation is high in pre-dialysis patients. High serum CRP levels predict a constant inflammatory state on follow-up. As occurs in dialysis patients, pre-dialysis inflammation predicts lower serum albumin concentration, poorer response to Epo, and a higher hospitalization rate. The decline in renal function does not seem to be related to the inflammatory state. Mortality was not affected on short-term follow-up.

Keywords: erythropoietin response; hospitalization; hypoalbuminaemia; inflammation; pre-dialysis

Correspondence and offprint requests to: Dr O. Ortega, Servicio Nefrología, Hospital Severo Ochoa, Avda. Orellana s/n, E-28911 Leganés, Madrid, Spain. Email: oortega{at}hsvo.insalud.es


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. Vickery, M. C. Webb, C. P. Price, R. I. John, N. A. Abbas, and E. J. Lamb
Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3546 - 3553.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M. E. Suliman, M. I. Yilmaz, J. J. Carrero, A. R. Qureshi, M. Saglam, O. M. Ipcioglu, M. Yenicesu, M. Tong, O. Heimburger, P. Barany, et al.
Novel Links between the Long Pentraxin 3, Endothelial Dysfunction, and Albuminuria in Early and Advanced Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 976 - 985.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Utaka, C. M Avesani, S. A Draibe, M. A Kamimura, S. Andreoni, and L. Cuppari
Inflammation is associated with increased energy expenditure in patients with chronic kidney disease
Am. J. Clinical Nutrition, October 1, 2005; 82(4): 801 - 805.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Y.-M. Wang, J. Woo, C. W.-K. Lam, M. Wang, M. M.-M. Sea, S.-F. Lui, P. K.-T. Li, and J. Sanderson
Is a Single Time Point C-Reactive Protein Predictive of Outcome in Peritoneal Dialysis Patients?
J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1871 - 1879.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.